STRO

Sutro Biopharma, Inc.

4.53 USD
-0.15 (-3.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sutro Biopharma, Inc. stock is up 20.16% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Apr 13:30 17 May, 2024 7.50 PUT 91 0

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. focuses on creating protein therapeutics for cancer and autoimmune disorders. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma.

  • Oppenheimer
    Wed May 15, 11:35
    buy
    confirm
  • Wedbush
    Tue May 14, 08:29
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 14, 07:17
    buy
    confirm
  • Bank of America
    Wed May 8, 06:15
    buy
    initial